FulHold: CHD-FA Information Website

FulHold (Ltd) is an international holding company that owns all  the Intellectual Property pertaining to an Active Pharmaceutical Ingrediant (API) used as a base in a variety of products; ranging from medicinal, cosmetic, and food supplement. This Intellectual Property includes world wide patents (see "Patents" above) and clinical trial results (see "Research" above).

This API is called CHD-FA (an acronym for CarboHydrate Derived Fulvic Acid).

Fulvic acid falls under the umbrella of naturally occurring “humic substances”, those organic compounds that arise from the decomposition of organic material in the environment. Fulvic acid is that unique fraction of humic substances that is soluble in water at all pH values. It is characterized by having a low pH, a low molecular weight, and a high cation exchange capacity. It is a colloidal material that can withstand both high and low temperatures. The properties of fulvic acid include having anti-bacterial, anti-fungal and anti-viral activity.

Then, why is it that fulvic acid has never risen to prominence in the cosmetic, pharmaceutical or food industry?

Humic substances have been known since the early days of coal tar soap, and fulvic acid is presently used for disease control in the production of organic crops. The answer lies in the fact that until recently, the only source of fulvic acid was from the environment. It has been extracted from many environmental sources including soil, peat, coal and even sewage. A consequence of fulvic acid’s colloidal properties allows it to bind to both organic and inorganic contaminants in the environment. This contamination of various sources of fulvic acid, along with the absence of consistent and uniform environmental deposits has been the main factor preventing the use of fulvic acid as an ingredient in human and animal products. With the worldwide deterioration of the environment, laboratory analysis of fulvic acid has invariably uncovered high levels of metals such as aluminum, arsenic and lead, as well as levels of pesticide and herbicide residues. Other fulvic acid producers that source fulvic acid from environmental deposits often hide this fact by marketing their products as "mineral" fulvic acid.

CHD-FA is produced in a state of the art facility by an industrial converter process that yields a form of fulvic acid from plant material, free of contaminants. The process yields a stable, uniform product that is safe for cosmetic, pharmaceutical and nutritional use.

Observational HIV Study

The following is the conclusion of the Observational Study of HIV patients using CHD-FA as active ingredient:

• It can therefore be concluded that The Product is well tolerated in patients suffering from HIV.
• The Product caused no liver or renal toxicity in these patients.
• The Product caused a statistically significant reduction of the viral loads of the pre-ART HIV positive patients. This effect needs further extrapolation in a randomized, double blind, controlled study.
• The pre- ART HIV patients on The Product reported a significant improvement of their well being proving the HA hypothesis that The Product does improve health related outcomes in patients with HIV.
• This study therefore supports further investigations into these effects in a more robust and interventional manner in order to test the validity of The Product as a possible complementary product to boost well being in HIV patients